New England Private Wealth Advisors LLC Eloxx Pharmaceuticals, Inc. Transaction History

New England Private Wealth Advisors LLC

  • $570 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020
SELL
$3.19 - $7.56 $175,450 - $415,800
-55,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$4.37 - $9.91 $21,850 - $49,550
5,000 Added 10.0%
55,000 $249,000
Q2 2019

Aug 08, 2019
SELL
$8.77 - $12.49 $706,484 - $1.01 Million
-80,557 Reduced 61.7%
50,000 $499,000
Q4 2018

Feb 12, 2019
BUY
$10.43 - $17.39 $1.36 Million - $2.27 Million
130,557 New
130,557 $1.57 Million

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track New England Private Wealth Advisors LLC Portfolio

Follow New England Private Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on New England Private Wealth Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email